Herausforderungen an die klinische Evaluation und Gesundheitsökonomie auf dem Weg zur personalisierten Medizin
Published 2012 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Herausforderungen an die klinische Evaluation und Gesundheitsökonomie auf dem Weg zur personalisierten Medizin
Authors
Keywords
-
Journal
Bundesgesundheitsblatt-Gesundheitsforschung-Gesundheitsschutz
Volume 55, Issue 5, Pages 710-714
Publisher
Springer Nature
Online
2012-04-24
DOI
10.1007/s00103-012-1479-2
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Cost-Effectiveness of Using Pharmacogenetic Information in Warfarin Dosing for Patients With Nonvalvular Atrial Fibrillation
- (2013) Mark H. Eckman ANNALS OF INTERNAL MEDICINE
- What principles should govern the use of managed entry agreements?
- (2011) Marianne Klemp et al. INTERNATIONAL JOURNAL OF TECHNOLOGY ASSESSMENT IN HEALTH CARE
- Methodological and practical challenges for personalized cancer therapies
- (2011) Ignacio I. Wistuba et al. Nature Reviews Clinical Oncology
- Bridging the efficacy–effectiveness gap: a regulator's perspective on addressing variability of drug response
- (2011) Hans-Georg Eichler et al. NATURE REVIEWS DRUG DISCOVERY
- Innovative tests for patient-tailored treatments: demonstrating value in the age of personalized medicine
- (2011) Laura Housman Personalized Medicine
- Challenge of evidence in individualized medicine
- (2011) Kathleen Kraft et al. Personalized Medicine
- Translational informatics in personalized medicine
- (2011) Eric D Perakslis et al. Personalized Medicine
- Contribution of VKORC1 and CYP2C9 polymorphisms in the interethnic variability of warfarin dose in Malaysian populations
- (2010) Gin Gin Gan et al. ANNALS OF HEMATOLOGY
- Risk sharing arrangements for pharmaceuticals: potential considerations and recommendations for European payers
- (2010) Jakub Adamski et al. BMC HEALTH SERVICES RESEARCH
- Designing a Randomized Clinical Trial to Evaluate Personalized Medicine: A New Approach Based on Risk Prediction
- (2010) S. G. Baker et al. JNCI-Journal of the National Cancer Institute
- Efficacy and safety of dabigatran compared with warfarin at different levels of international normalised ratio control for stroke prevention in atrial fibrillation: an analysis of the RE-LY trial
- (2010) Lars Wallentin et al. LANCET
- Personalized medicine in oncology: the future is now
- (2010) Richard L. Schilsky NATURE REVIEWS DRUG DISCOVERY
- Cost Effectiveness of Pharmacogenomics
- (2010) William B. Wong et al. PHARMACOECONOMICS
- Clinical Trial Designs for Predictive Biomarker Validation: Theoretical Considerations and Practical Challenges
- (2009) Sumithra J. Mandrekar et al. JOURNAL OF CLINICAL ONCOLOGY
- Prospective Cost-Effectiveness Analysis of Cetuximab in Metastatic Colorectal Cancer: Evaluation of National Cancer Institute of Canada Clinical Trials Group CO.17 Trial
- (2009) N. Mittmann et al. JNCI-Journal of the National Cancer Institute
- Next generation oncology drug development: opportunities and challenges
- (2009) Martin E. Gutierrez et al. Nature Reviews Clinical Oncology
- The microeconomics of personalized medicine: today's challenge and tomorrow's promise
- (2009) Jerel C. Davis et al. NATURE REVIEWS DRUG DISCOVERY
- Pharmacoeconomic Evaluations of Pharmacogenetic and Genomic Screening Programmes
- (2009) Stefan Vegter et al. PHARMACOECONOMICS
- A Policy Model to Evaluate the Benefits, Risks and Costs of Warfarin Pharmacogenomic Testing
- (2009) Lisa M. Meckley et al. PHARMACOECONOMICS
- Impact of VKORC1 gene polymorphism on interindividual and interethnic warfarin dosage requirement— A systematic review and meta analysis
- (2009) Limei Yang et al. THROMBOSIS RESEARCH
- On the Eve of Personalized Medicine in Oncology
- (2008) T. J. Yeatman et al. CANCER RESEARCH
- Bayesian adaptive design for targeted therapy development in lung cancer — a step toward personalized medicine
- (2008) Xian Zhou et al. Clinical Trials
- Healthcare impact of personalized medicine using genetic testing: an exploratory analysis for warfarin
- (2008) Andrew McWilliam et al. Personalized Medicine
- A paucimorphic variant in the HMG-CoA reductase gene is associated with lipid-lowering response to statin treatment in diabetes: a GoDARTS study
- (2008) Louise A. Donnelly et al. Pharmacogenetics and Genomics
Publish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn MoreFind the ideal target journal for your manuscript
Explore over 38,000 international journals covering a vast array of academic fields.
Search